Head & Neck Cancer, 4th ed.

本書の特色

頭頸部癌のあらゆる側面を幅広く解説する集学的テキスト，改訂第4版．腫瘍外科医，放射線腫瘍医，腫瘍内科医，歯科医，病理医，放射線科医，看護師といった広範な専門家に有用な内容となっている．

【ここに注目!!】
‐8つの新章を設け，9つの章で新たな執筆者を迎えた．
‐最新の手技と画像診断に重点を置いて改訂された．
‐最新の画像診断について，診断，画像ガイド下の治療，フォローアップの画像診断，新たな画像診断アプローチを強調している．
‐基礎科学の記述を減らし，臨床診断と治療の内容を拡充した．
‐図版の25％を一新し，診断と治療を助けるカラー画像を増やした．

Table of Contents
SECTION 1: General Principles of Management of Head and Neck Cancer
1 General Principles of Head and Neck Pathology
2 Clinical Evaluation of the Head and Neck Cancer Patient
3 Prognostic Factors in Patients with Head and Neck Cancer
4 Radiologic Evaluation of the Head and Neck Cancer Patient
5 Novel Radiation Therapy Techniques in the Management of Head and Neck Cancer
6 New Approaches: Robotics and Endoscopic Head and Neck Surgery
7 Targeted Agents in Squamous Cell Carcinoma of the Head and Neck
8 Multidisciplinary Reconstruction of the Head and Neck: General Principles
9 Dental Oncology and Maxillofacial Prosthetics
10 Interdisciplinary Symptom Management
11 Evaluation and Rehabilitation of Speech, Voice, and Swallowing Functions after Treatment of Head and Neck Cancer
12 Human Papillomavirus–Associated Head and Neck Carcinoma
13 Chemoprevention
SECTION 2: Site-Specific Principles of Managementof Head and Neck Cancer
14 Management of the Neck
15 Metastatic Cancer to the Neck from an Unknown Primary Site
16 Cancer of the Oral Cavity
17 Cancer of the Oropharynx
18 Cancer of the Larynx
19 Cancers of the Hypopharynx and Cervical Esophagus
20 Cancer of the Nasal Vestibule, Nasal Cavity, Paranasal Sinuses, Anterior Skull Base, and Orbit: Surgical Management
21 Cancer of the Nasal Cavity and Paranasal Sinus: Radiation Therapy and Chemotherapy Management
22 Cancer of the Nasopharynx
23 Basal and Squamous Cell Skin Cancers
24 Melanoma of the Head and Neck
25 Management of Salivary Gland Tumors
26 Primary and Recurrent Disease of the Lateral Skull Base
27 Paragangliomas of the Head and Neck
28 Cancer of the Thyroid and Parathyroid
29 Soft Tissue and Bone Sarcomas of the Head and Neck
30 Systemic Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Cancer